CLS Holdings plc (LON:CLI – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 53.05 and traded as low as GBX 47.95. CLS shares last traded at GBX 50.20, with a volume of 121,166 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank lowered their price target on CLS from GBX 80 to GBX 58 and set a “buy” rating on the stock in a report on Wednesday, May 6th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of GBX 64.
Get Our Latest Stock Report on CLI
CLS Stock Performance
Insiders Place Their Bets
In other news, insider Fredrik Widlund acquired 100,000 shares of the stock in a transaction that occurred on Wednesday, April 29th. The shares were purchased at an average cost of GBX 49 per share, for a total transaction of £49,000. In the last 90 days, insiders have acquired 120,408 shares of company stock valued at $5,839,964. Company insiders own 60.13% of the company’s stock.
CLS Company Profile
We are a commercial property investment company with a £2.1bn portfolio listed on the Premium Main Market on the London Stock Exchange, specialising in future-focused office space in the UK, Germany and France. Through geographical diversification, local expertise and an active management approach, we transform office properties into sustainable, modern spaces that help our tenants’ businesses to grow.
Further Reading
- Five stocks we like better than CLS
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.
